.
MergerLinks Header Logo

New Deal


Announced

Completed

Bain Capital-led consortium completed the $145m investment in BioCatch.

Financials

Edit Data
Transaction Value£115m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Single Bidder

biometrics

Friendly

Majority

Acquisition

Private Equity

Completed

Israel

Biotechnology

Private

Synopsis

Edit

Bain Capital-led consortium completed the $145m investment in BioCatch, a Tel Aviv-based biometrics company. Also joining the round are new investors including Industry Ventures as well as existing shareholders American Express Ventures, CreditEase, Maverick Ventures and OurCrowd, among others. “BioCatch has quickly established itself as a pioneer in the digital identity space by developing next-generation behavioral biometrics technology that integrates fraud detection and authentication capabilities to protect end-users and their most sensitive transactions. Their technology is highly applicable to other verticals beyond financial services that have the same need to balance fraud and the user experience,” Dewey Awad, Bain Capital Tech Opportunities Managing Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US